What is NDC 55150-180?

55150-180 is the product NDC for Amiodarone Hydrochloride, Amiodarone hydrochloride 150 mg/3mL injection, solution, listed with the FDA by AuroMedics Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

AuroMedics Pharma LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Amiodarone Hydrochloride?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Amiodarone Hydrochloride NDC 55150-180

NDC codes

FDA NDC Directory

Product NDC (as listed)55150-180Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55150-0180Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55150-180-03	55150018003	10 VIAL, SINGLE-DOSE in 1 CARTON (55150-180-03) / 3 mL in 1 VIAL, SINGLE-DOSEMarketed from Oct 25, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Amiodarone Hydrochloride
Generic name (nonproprietary): amiodarone hydrochloride
Active ingredients: Amiodarone hydrochloride — 150 mg/3mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: AuroMedics Pharma LLCNDC labeler code 55150
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204550
Marketing start: Oct 25, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Cytochrome P450 1A2 Inhibitors (Mechanism)Cytochrome P450 2C9 Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
Identifiers: Product ID 55150-180_c2e4f552-4ed1-4c8c-b865-39596b79b1adSPL ID c2e4f552-4ed1-4c8c-b865-39596b79b1adSPL set ID 6cd870d7-6381-421a-89bc-bce5c9518219RxCUI 833532, 1663224, 1663244UNII 976728SY6ZUPC 0355150180035, 0355150182183, 0355150181094
Pharmacologic class: Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N455150018003 followed by a unit qualifier and the quantity

Package 55150-0180-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 8, 2021.

Indications (excerpt from the label)

Amiodarone hydrochloride injection is indicated for initiation of treatment and prophylaxis of frequently recurring ventricular fibrillation (VF) and hemodynamically unstable ventricular tachycardia (VT) in patients refractory to other therapy. Amiodarone also can be used to treat patients with VT/VF for whom oral amiodarone is indicated, but who are unable to take oral medication. During or after treatment with amiodarone, patients may be transferred to oral amiodarone therapy [see Dosage and Administration (2) ] . Use amiodarone for acute treatment until the patient's ventricular arrhythmias are stabilized. Most patients will require this therapy for 48 to 96 hours, but amiodarone may be s…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 55150-180

What is NDC 55150-180?: 55150-180 is the product NDC for Amiodarone Hydrochloride, Amiodarone hydrochloride 150 mg/3mL injection, solution, listed with the FDA by AuroMedics Pharma LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Amiodarone Hydrochloride.
What is the active ingredient?: Amiodarone hydrochloride.
Who is the labeler?: AuroMedics Pharma LLC, NDC labeler code 55150. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Amiodarone Hydrochloride?: 61 other product NDCs are listed under this name. See all Amiodarone Hydrochloride NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Amiodarone Hydrochloride NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
amiodarone hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Safecor Health LLC	48433-154	48433-0154-20
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Major Pharmaceuticals	0904-7576	00904-7576-61
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Henry Schein, Inc.	0404-9772	00404-9772-03
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-643	65219-0643-03
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Fresenius Kabi USA, LLC	65219-645	65219-0645-09
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Slate Run Pharmaceuticals	70436-232	70436-0232-5070436-0232-5270436-0232-62
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC.	71872-7354	71872-7354-01
Amiodarone Hydrochloride	Amiodarone hydrochloride 100 mg/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-005	75907-0005-30
Amiodarone Hydrochloride	Amiodarone hydrochloride 200 mg/1	TabletOral	Dr. Reddy's Labratories Inc.	75907-006	75907-0006-60
Amiodarone Hydrochloride	Amiodarone hydrochloride 50 mg/mL	Injection, SolutionIntravenous	Mylan Institutional LLC	72078-046	72078-0046-0972078-0046-18

All 62 Amiodarone Hydrochloride NDCs

Other NDCs under ANDA 204550

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 204550
Product	Strength	Form · route	Labeler	Product NDC
Amiodarone Hydrochloride	Amiodarone hydrochloride 450 mg/9mL	Injection, SolutionIntravenous	AuroMedics Pharma LLC	55150-181
Amiodarone Hydrochloride	Amiodarone hydrochloride 900 mg/18mL	Injection, SolutionIntravenous	AuroMedics Pharma LLC	55150-182
Amiodarone Hydrochloride	Amiodarone hydrochloride 150 mg/3mL	Injection, SolutionIntravenous	Medical Purchasing Solutions, LLC	71872-7149